- 1.
Clayton-Smith J, Bromley R, Dean J et al. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability. Orphanet J Rare Dis 2019; 14: 180. [PubMed][CrossRef]
- 2.
Tomson T, Battino D, Bonizzoni E et al. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology 2015; 85: 866–72. [PubMed][CrossRef]
- 3.
Christensen J, Grønborg TK, Sørensen MJ et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696–703. [PubMed][CrossRef]
- 4.
Bromley R, Weston J, Adab N et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014; 10: CD010236. [PubMed][CrossRef]
- 5.
Husebye ESN, Gilhus NE, Riedel B et al. Verbal abilities in children of mothers with epilepsy: Association to maternal folate status. Neurology 2018; 91: e811–21. [PubMed][CrossRef]
- 6.
Christensen J, Pedersen L, Sun Y et al. Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit/hyperactivity disorder in offspring. JAMA Netw Open 2019; 2: e186606. [PubMed][CrossRef]
- 7.
Elkjær LS, Bech BH, Sun Y et al. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children. JAMA Neurol 2018; 75: 663–71. [PubMed][CrossRef]
- 8.
European Medicines Agency. CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls 2014 https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances Lest 24.3.2020.
- 9.
Vindsland S. Kan gi autisme, adhd, lavere IQ og misdannelser. Fædrelandsvennen 2016. https://www.fvn.no/nyheter/lokalt/i/E5gmA/kan-gi-autisme-adhd-lavere-iq-og-misdannelser Lest 24.3.2020.
- 10.
European Medicines Agency. Valproate and related substances. https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances-0 Lest 24.3.2020.
- 11.
Felleskatalogen. Informasjon om risiko for kvinnelige pasienter og gravide kvinner ved bruk av valproat (Orfiril, Orfiril long, Orifiril retard). Felleskatalogen. Oslo: Statens Legemiddelverk, 2018 https://www.felleskatalogen.no/medisin/dokument/valproat-veiledning-helsepersonell Lest 24.3.2020.
- 12.
Alvestad S, Bjørnvold M, Molteberg E et al. Valproat fortsatt viktig for kvinner med generalisert epilepsi. Tidsskr Nor Legeforen 2019; 139. doi: 10.4045/tidsskr.19.0220. [PubMed][CrossRef]
- 13.
Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016–26. [PubMed][CrossRef]
- 14.
Tabrizi N, Zarvani A, Rezaei P et al. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial. Epilepsy Res 2019; 157: 106214. [PubMed][CrossRef]
- 15.
Tomson T, Battino D, Bonizzoni E et al. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP. Epilepsia 2016; 57: e173–7. [PubMed][CrossRef]
- 16.
Cerulli Irelli E, Morano A, Cocchi E et al. Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome. Epilepsia 2020; 61: 107–14. [PubMed][CrossRef]
- 17.
Knight M, Nair M, Tuffnell D et al. red. Saving lives, improving mothers' care ‒ Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2013–15. Oxford: Epidemiology Unit, University of Oxford, 2017. https://www.npeu.ox.ac.uk/downloads/files/mbrrace-uk/reports/MBRRACE-UK%20Maternal%20Report%202017%20-%20Web.pdf Lest 24.3.2020.
- 18.
Tomson T, Battino D, Bonizzoni E et al. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP. Neurology 2015; 85: 580–8. [PubMed][CrossRef]
- 19.
Rauchenzauner M, Ehrensberger M, Prieschl M et al. Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy–a matter of importance for the baby? J Neurol 2013; 260: 484–8. [PubMed][CrossRef]
- 20.
Adab N, Kini U, Vinten J et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 1575–83. [PubMed][CrossRef]
- 21.
Minkoff H, Schaffer RM, Delke I et al. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol 1985; 65: 22S–4S. [PubMed]
- 22.
do Vale TG, da Silva AV, Lima DC et al. Seizures during pregnancy modify the development of hippocampal interneurons of the offspring. Epilepsy Behav 2010; 19: 20–5. [PubMed][CrossRef]
- 23.
Lima DC, Vale TG, Arganãraz GA et al. Behavioral evaluation of adult rats exposed in utero to maternal epileptic seizures. Epilepsy Behav 2010; 18: 45–9. [PubMed][CrossRef]
- 24.
Bromley RL, Baker GA, Clayton-Smith J et al. Intellectual functioning in clinically confirmed fetal valproate syndrome. Neurotoxicol Teratol 2019; 71: 16–21. [PubMed][CrossRef]
- 25.
Kunnskapsbasert retningslinje om epilepsi. https://www.epilepsibehandling.no/ Lest 24.3.2020.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.
Hva med barn som behandles med Valproat?
11.05.2020Takk for viktig påminning om risiko for fosterskade ved bruk av valproat hos gravide kvinner. Den relative risikoøkningen for autisme, ADHD og lavere IQ-skåre hos barna er virkelig urovekkende stor, og valproateksponering står i en særstilling blant ellers…